Form 4 for BSX Boston Scientific
Accepted 2021-09-08 00:00:00 ET · period of report 2021-09-07 · accession 0001225208-21-012144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-08 | 2021-09-07 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $6.64 | +201.0K | 2.22M | +10% | +$1.34M |
| D | 2021-09-08 | 2021-09-07 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $44.57 | -201.0K | 2.08M | -9% | -$8.96M |
| DM | 2021-09-08 | 2021-09-07 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -201.0K | 462.4K | -30% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | M | A | 66,053 | $7.39 | 2,282,863 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-07 | M | A | 134,988 | $6.28 | 2,216,810 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-07 | S | D | 201,041 | $44.57 | 2,081,822 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.34 to $44.71, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-09-07 | M | D | 134,988 | $0.00 | 269,976 | D | $6.28 · — to 2022-02-27 | 134,988 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-09-07 | M | D | 66,053 | $0.00 | 462,376 | D | $7.39 · — to 2023-02-28 | 66,053 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. |